Please enable Javascript
Namrata Vijayvergia, MD
Namrata Vijayvergia, MD, Gastrointestinal Medical Oncology, Fox Chase Cancer Center
Articles by Namrata Vijayvergia, MD
Toxicities and Duration of Treatment for Immunotherapy in Advanced HCC
Namrata Vijayvergia, MD
Unresectable HCC
|
March 13, 2025
Drs. Vijayvergia and Lieu conclude with considerations for managing IO-related toxicities in patients with metastatic HCC.
View More
Biomarkers of Response and Sequencing for Immunotherapy in Advanced HCC
Namrata Vijayvergia, MD
Unresectable HCC
|
March 13, 2025
Drs. Vijayvergia and Lieu continue their discussion with attention to biomarkers of response for immunotherapy in mHCC.
View More
Analyzing the Immunotherapy Landscape for Advanced HCC
Namrata Vijayvergia, MD
Unresectable HCC
|
March 13, 2025
Drs. Vijayvergia and Lieu detail the considerations for administering immunotherapy to their patients with metastatic HCC.
View More